Maintenance olaparib improves OS in relapsed ovarian cancer with BRCA1/2 mutation Presented ByProf. Andrés Poveda, Hospital Quironsalud, Spain TrialPhase 3, SOLO2/ENGOT-ov21 ConferenceASCO 2020 8 September 2020 09:35